SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,964 | +2.3% | 1,555,514 | +16.0% | 0.01% | 0.0% |
| Q2 2023 | $35,152 | +399.4% | 1,340,630 | +390.3% | 0.01% | +400.0% |
| Q1 2023 | $7,039 | +13.4% | 273,427 | +14.6% | 0.00% | 0.0% |
| Q4 2022 | $6,207 | -99.9% | 238,653 | -4.1% | 0.00% | 0.0% |
| Q3 2022 | $7,101,000 | +19.5% | 248,855 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $5,944,000 | -66.6% | 241,443 | -23.5% | 0.00% | -50.0% |
| Q1 2022 | $17,804,000 | -7.9% | 315,442 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $19,340,000 | -0.8% | 312,041 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $19,502,000 | -23.4% | 307,407 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $25,459,000 | +5.6% | 308,937 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $24,107,000 | +1.9% | 327,679 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $23,655,000 | – | 326,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |